标题
Molecular Mechanisms and Therapeutics for SCA17
作者
关键词
Polyglutamine, SCA17, TBP, transcription, neurodegeneration, muscle atrophy
出版物
Neurotherapeutics
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-07-18
DOI
10.1007/s13311-019-00762-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Expanding Clinical Universe of Polyglutamine Disease
- (2019) Shanshan Huang et al. NEUROSCIENTIST
- Shaoyao Gancao Tang (SG-Tang), a formulated Chinese medicine, reduces aggregation and exerts neuroprotection in spinocerebellar ataxia type 17 (SCA17) cell and mouse models
- (2019) Chiung-Mei Chen et al. Aging-US
- Piperine ameliorates SCA17 neuropathology by reducing ER stress
- (2018) Jifeng Guo et al. Molecular Neurodegeneration
- The indole compound NC009-1 inhibits aggregation and promotes neurite outgrowth through enhancement of HSPB1 in SCA17 cells and ameliorates the behavioral deficits in SCA17 mice
- (2018) Chiung-Mei Chen et al. NEUROTOXICOLOGY
- CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington’s disease
- (2017) Su Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- Synergistic Toxicity of Polyglutamine-Expanded TATA-Binding Protein in Glia and Neuronal Cells: Therapeutic Implications for Spinocerebellar Ataxia 17
- (2017) Yang Yang et al. JOURNAL OF NEUROSCIENCE
- The Anti-CRISPR Story: A Battle for Survival
- (2017) Karen L. Maxwell MOLECULAR CELL
- BIIB021, a synthetic Hsp90 inhibitor, induces mutant ataxin-1 degradation through the activation of heat shock factor 1
- (2016) Ying Ding et al. NEUROSCIENCE
- A patient with 41 CAG repeats in SCA17 presenting with parkinsonism and chorea
- (2016) Hyeyoung Park et al. PARKINSONISM & RELATED DISORDERS
- An miRNA-mediated therapy for SCA6 blocks IRES-driven translation of the CACNA1A second cistron
- (2016) Yu Miyazaki et al. Science Translational Medicine
- Gene suppression strategies for dominantly inherited neurodegenerative diseases: lessons from Huntington's disease and spinocerebellar ataxia
- (2015) Megan S. Keiser et al. HUMAN MOLECULAR GENETICS
- Piperine inhibit inflammation, alveolar bone loss and collagen fibers breakdown in a rat periodontitis model
- (2015) Y. Dong et al. JOURNAL OF PERIODONTAL RESEARCH
- Trehalose Attenuates the Gait Ataxia and Gliosis of Spinocerebellar Ataxia Type 17 Mice
- (2015) Zhi-Zhong Chen et al. NEUROCHEMICAL RESEARCH
- Large Polyglutamine Repeats Cause Muscle Degeneration in SCA17 Mice
- (2015) Shanshan Huang et al. Cell Reports
- Nonallele Specific Silencing of Ataxin-7 Improves Disease Phenotypes in a Mouse Model of SCA7
- (2014) Pavitra S Ramachandran et al. MOLECULAR THERAPY
- Age-Dependent Decrease in Chaperone Activity Impairs MANF Expression, Leading to Purkinje Cell Degeneration in Inducible SCA17 Mice
- (2014) Su Yang et al. NEURON
- Muscle Expression of Mutant Androgen Receptor Accounts for Systemic and Motor Neuron Disease Phenotypes in Spinal and Bulbar Muscular Atrophy
- (2014) Constanza J. Cortes et al. NEURON
- Psychiatric onset and late chorea in a patient with 41 CAG repeats in the TATA-binding protein gene
- (2014) Alessia Alibardi et al. PARKINSONISM & RELATED DISORDERS
- Peripheral Androgen Receptor Gene Suppression Rescues Disease in Mouse Models of Spinal and Bulbar Muscular Atrophy
- (2014) Andrew P. Lieberman et al. Cell Reports
- Automated home cage assessment shows behavioral changes in a transgenic mouse model of spinocerebellar ataxia type 17
- (2013) Esteban Portal et al. BEHAVIOURAL BRAIN RESEARCH
- A Novel Transgenic Rat Model for Spinocerebellar Ataxia Type 17 Recapitulates Neuropathological Changes and Supplies In Vivo Imaging Biomarkers
- (2013) A. Kelp et al. JOURNAL OF NEUROSCIENCE
- Silencing Mutant ATXN3 Expression Resolves Molecular Phenotypes in SCA3 Transgenic Mice
- (2013) Edgardo Rodríguez-Lebrón et al. MOLECULAR THERAPY
- Late onset ataxia: MSA-C or SCA 17? A gene penetrance dilemma
- (2013) Karen M. Doherty et al. MOVEMENT DISORDERS
- Hsp104 Suppresses Polyglutamine-Induced Degeneration Post Onset in a Drosophila MJD/SCA3 Model
- (2013) Mimi Cushman-Nick et al. PLoS Genetics
- The unfolded protein response: controlling cell fate decisions under ER stress and beyond
- (2012) Claudio Hetz NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Neuronal expression of TATA box-binding protein containing expanded polyglutamine in knock-in mice reduces chaperone protein response by impairing the function of nuclear factor-Y transcription factor
- (2011) Shanshan Huang et al. BRAIN
- A Drosophila model of the neurodegenerative disease SCA17 reveals a role of RBP-J/Su(H) in modulating the pathological outcome
- (2011) Jie Ren et al. HUMAN MOLECULAR GENETICS
- Neuroprotective effects of granulocyte-colony stimulating factor in a novel transgenic mouse model of SCA17
- (2011) Ya-Chin Chang et al. JOURNAL OF NEUROCHEMISTRY
- Pathology of CAG repeat diseases
- (2010) Mitsunori Yamada et al. NEUROPATHOLOGY
- Transcriptional dysregulation of TrkA associates with neurodegeneration in spinocerebellar ataxia type 17
- (2009) A. G. Shah et al. HUMAN MOLECULAR GENETICS
- Mesencephalic Astrocyte-Derived Neurotrophic Factor Is Neurorestorative in Rat Model of Parkinson's Disease
- (2009) M. H. Voutilainen et al. JOURNAL OF NEUROSCIENCE
- Huntington's disease-like and ataxia syndromes: Identification of a family with a de novo SCA17/TBP mutation
- (2009) Sara Bech et al. PARKINSONISM & RELATED DISORDERS
- Anti-inflammatory and antiarthritic effects of piperine in human interleukin 1β-stimulated fibroblast-like synoviocytes and in rat arthritis models
- (2009) Jun Soo Bang et al. ARTHRITIS RESEARCH & THERAPY
- Polyglutamine Expansion Reduces the Association of TATA-binding Protein with DNA and Induces DNA Binding-independent Neurotoxicity
- (2008) Meyer J. Friedman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- In vivo suppression of polyglutamine neurotoxicity by C-terminus of Hsp70-interacting protein (CHIP) supports an aggregation model of pathogenesis
- (2008) Aislinn J. Williams et al. NEUROBIOLOGY OF DISEASE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started